UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
CRVO holding history
CervoMed Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRVO overviewAll 13F holders of CRVOFull Q2 2026 holdings
- Shares (Q2 2026)
- 992
- Value
- $3.08K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 992 | $3.08K | <0.1% | −4,247−81.1% | Reduced | Holders |
| Q1 2026 | 5,239 | $20.6K | <0.1% | +4,196+402.3% | Added | Holders |
| Q4 2025 | 1,043 | $8.24K | <0.1% | −2,333−69.1% | Reduced | Holders |
| Q3 2025 | 3,376 | $27.3K | <0.1% | −2,217−39.6% | Reduced | Holders |
| Q2 2025 | 5,593 | $35.2K | <0.1% | −1,194−17.6% | Reduced | Holders |
| Q1 2025 | 6,787 | $62.1K | <0.1% | −36,578−84.3% | Reduced | Holders |
| Q4 2024 | 43,365 | $101.5K | <0.1% | +40,828+1,609.3% | Added | Holders |
| Q3 2024 | 2,537 | $37.0K | <0.1% | +903+55.3% | Added | Holders |
| Q2 2024 | 1,634 | $28.0K | <0.1% | +1,634 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −60−100.0% | Sold out | Holders |
| Q2 2023 | 60 | $200 | <0.1% | −410−87.2% | Reduced | Holders |
| Q1 2023 | 470 | $1.95K | <0.1% | +147+45.5% | Added | Holders |
| Q4 2022 | 323 | $1.63K | <0.1% | −533−62.3% | Reduced | Holders |
| Q3 2022 | 856 | $5.00K | <0.1% | +426+99.1% | Added | Holders |
| Q2 2022 | 430 | $3.00K | <0.1% | +430 | New | Holders |